Sally E Mitchell
Overview
Explore the profile of Sally E Mitchell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Temple M, Abruzzo T, Munoz F, Amaral J, Bogan K, Gibson C, et al.
Pediatr Radiol
. 2023 Aug;
53(11):2245-2252.
PMID: 37568041
Background: Due to the rarity of pediatric diseases, collaborative research is the key to maximizing the impact of research studies. A research needs assessment survey was created to support initiatives...
2.
Yuan F, Gong A, Gowda P, Khalil A, Farhan A, Hafezi-Nejad N, et al.
J Vasc Interv Radiol
. 2023 May;
34(9):1609-1617.e2.
PMID: 37187436
Purpose: To evaluate whether intraoperative neuromonitoring (IONM), including pre-embolization lidocaine injection challenge ("provocative testing") is associated with reduced risk of irreversible nerve injury during embolization of peripheral arteriovenous malformations (AVMs)....
3.
Latif M, Bailey C, Motaghi M, Abou Areda M, Galiatsatos P, Mitchell S, et al.
AJR Am J Roentgenol
. 2022 Aug;
220(1):95-103.
PMID: 35946857
Endovascular embolization of pulmonary arteriovenous malformations (PAVMs) was historically performed with embolic coils. The Amplatzer Vascular Plug device (AVP) was introduced for this purpose in 2007 and the Micro Vascular...
4.
Milbar H, Jeon H, Ward M, Mitchell S, Weiss C, Cohen B
J Vasc Interv Radiol
. 2019 Apr;
30(9):1438-1442.
PMID: 30956080
The present report documents 6 patients who developed distinctive hyperpigmented skin lesions after bleomycin sclerotherapy for vascular malformations of the face, neck, and extremities. The patients ranged in age from...
5.
Ali S, Mitchell S
Semin Intervent Radiol
. 2017 Sep;
34(3):288-293.
PMID: 28955118
It is very important that patients seeking sclerotherapy for the treatment of venous malformations are aware of the expected course of the therapy. They should be thoroughly counseled about the...
6.
Holly B, Patel Y, Park J, Fayad L, Deune E, Mitchell S, et al.
Hand (N Y)
. 2017 Jun;
12(4):335-341.
PMID: 28644938
Background: The standard of care for treatment of low-flow venous malformations (VMs) is percutaneous sclerotherapy. These lesions are seldom surgically resected, especially if the malformation is in an anatomically difficult...
7.
Nirmalarajan S, Borowski A, Gearhart J, Mitchell S, Weiss C
J Vasc Interv Radiol
. 2016 Dec;
27(11):1768-1770.
PMID: 27926419
No abstract available.
8.
Ali S, Weiss C, Sinha A, Eng J, Mitchell S
Phlebology
. 2016 Mar;
31(9):603-9.
PMID: 27009607
Purpose: We report a retrospective analysis of venous malformation patients treated with percutaneous sclerotherapy, describing their clinical manifestations, therapeutic outcomes and procedural complications. Materials And Methods: We reviewed our Vascular...
9.
Yin L, Reh D, Hoag J, Mitchell S, Mathai S, Robinson G, et al.
Laryngoscope
. 2015 Sep;
126(5):1029-32.
PMID: 26393959
Objectives/hypothesis: Hereditary hemorrhagic telangiectasia (HHT) is a disease of abnormal angiogenesis, causing epistaxis in over 96% of patients. The Epistaxis Severity Score (ESS) was developed as a standardized measurement of...
10.
Haq F, Mitchell S, Tekes A, Weiss C
J Vasc Interv Radiol
. 2015 Jul;
26(10):1484-93.
PMID: 26164845
Purpose: To report clinical and radiographic outcomes of patients with venous malformations (VMs) treated with bleomycin foam. Materials And Methods: Twenty patients (age, 2-68 y) presented with symptoms of swelling...